NEW ORLEANS, Feb. 14, 2020 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits:
Mattel, Inc. (MAT)
Class Period: 8/2/2017 – 8/8/2019
Lead Plaintiff Motion Deadline: February 24, 2020
To learn more, visit https://www.claimsfiler.com/cases/nasdaq-mat-3
Trulieve Cannabis Corp. (TCNNF)
Class Period: 9/25/2018 – 12/17/2019
Lead Plaintiff Motion Deadline: February 28, 2020
To learn more, visit https://www.claimsfiler.com/cases/view-trulieve-cannabis-corp-securities-litigation
Forescout Technologies, Inc. (FSCT)
Class Period: 2/7/2019 – 10/9/2019
Lead Plaintiff Motion Deadline: March 2, 2020
To learn more, visit https://www.claimsfiler.com/cases/view-forescout-technologies-inc-securities-litigation
Portola Pharmaceuticals, Inc. (PTLA)
Class Period: 5/8/2019 – 1/9/2020
Lead Plaintiff Motion Deadline: March 16, 2020
To learn more, visit https://www.claimsfiler.com/cases/view-portola-pharmaceuticals-inc-securities-litigation
If you purchased shares of the above companies and would like to discuss your legal rights and your right to recover for your economic loss, you may, without obligation or cost to you, contact us toll-free (844) 367-9658 or visit the case links above.
If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com
- Ascendis Pharma A/S Announces Preliminary Six-Month Data from Open-Label Extension of Phase 2 PaTH Forward Trial and Files IND Amendment to Initiate Phase 3 PaTHway Trial of TransCon™ PTH in Adult Hypoparathyroidism - September 29, 2020
- A sacred dialogue between a great counselor and his son presents deep meditative truths that will awaken readers’ hearts - September 29, 2020
- Lang Charters shows how life not only made more sense, but got better when it fell apart in his new memoir - September 29, 2020